Introduction European Urology Supplements John Anderson  European Urology Supplements  Volume 2, Issue 9, Pages 1-6 (December 2003) DOI: 10.1016/j.eursup.2003.10.003

Fig. 1 Trends for the use of radical prostatectomy and radiotherapy in the treatment of prostate cancer in recent decades [17]. European Urology Supplements 2003 2, 1-6DOI: (10.1016/j.eursup.2003.10.003)

Fig. 2 Disease-management algorithm for prostate cancer (reproduced from [28] with kind permission from Prescriber Magazine). BPH, benign prostatic hyperplasia; CT, computed tomography; DRE, digital rectal examination; LHRH, luteinizing hormone-releasing hormone; MRI, magnetic resonance imaging; PSA, prostate-specific antigen; TRUS, transrectal ultrasound. European Urology Supplements 2003 2, 1-6DOI: (10.1016/j.eursup.2003.10.003)

Fig. 3 Trial design for the bicalutamide 150mg Early Prostate Cancer program [36]. PSA, prostate-specific antigen. European Urology Supplements 2003 2, 1-6DOI: (10.1016/j.eursup.2003.10.003)